期刊文献+

小剂量螺内酯联合卡维地洛治疗慢性心力衰竭的疗效观察 被引量:6

Clinical efficacy of low-dose spironolactone combined with carvedilol in patients with chronic heart failure
暂未订购
导出
摘要 目的探讨小剂量螺内酯联合卡维地洛治疗慢性心力衰竭(CHF)患者的临床疗效。方法将136例CHF患者随机分为两组,每组68例,两组均使用常规治疗,观察组再加用小剂量螺内酯和卡维地洛治疗,随访10个月,评估心功能分级变化,超声心动图测量左室舒张末期内径(LVDD),左室收缩末期内径(LVSD),左室射血分数(LVEF),每搏输出量(SV),心脏指数(CI)。结果(1)两组治疗后均有效,观察组心功能改善显著,总有效率明显优于对照组(92.5% VS 73.5%,P<0.05),(2)观察组超声心动图测量的各项指标变化显著。结论CHF患者长期使用小剂量螺内酯和卡维地洛有益于改善心功能,提高生活质量。 Objective To study the clinical efficacy of low - dose spironolactone combined with carvedilol in patients with chronic heart failure (CHF). Methods One hundred and thirty six CHF patients were randomly divided into two groups of 68 each and both groups received conventional treatment. The observation group was administered additionally low - dose spironolactone and carvedilol. The changes in cardiac function grades were assessed by echocardiography to measure left ventricular end diastolic diameter (LVDD), left ventricular end systolic diameter (LVSD), left ventricular ejection fraction (LVEF), stroke volume (SV), and cardiac index (CI). Results The treatment was effective in the two groups. Cardiac function was significantly improved in the observation group,the total effective rate was higher than that in the control group (92.5% vs 73.5%, P 〈0.05). Indicators measured by echo- cardiography were changed significantly in the observation Group. Conclusions Longterm low- dose spironolactone and carvedilol therapy improves cardiac function and quality of life in CHF patients.
出处 《武警医学》 CAS 2009年第10期917-919,共3页 Medical Journal of the Chinese People's Armed Police Force
关键词 螺内酯 卡维地洛 慢性心力衰竭 Spironolactone Carvedilol Chronic heart failure
  • 相关文献

参考文献4

二级参考文献13

  • 1[1]Diez J, Lavindes C, Mayor G, et al. Incrcased serum concentrations of procollagen peptides in essential hypertension relation to cardiac alterations [ J ]. Circulation, 1995,91:1450 - 1456
  • 2[2]Lundgren Eullberg D, Rubin K, et al. In vitro studies on adult cardiac myoeytes: Attachment and biosynthesis of collagen type Ⅳand laminin[J].J Cell Physiol,1998,136:43-53
  • 3[4]Klappacher G, Franzen P, Haab D, et al. Measuring extracelluar matrix tumover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis [J]. Am J Cardiol,1995,75:913 - 918
  • 4[5]Pitt B. "Escape"of aldosterone sterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor; implications for therapy[J]. Cardiovasc Drugs Ther, 1995,9:145 - 149
  • 5[6]Briua CG, Zhou GP, Rupp H, et al. Role of angiotensin Ⅱ and pro- Staglandin E2 in regulating cardiac fiberoblast collagen tullagen tumover[J]. Am J Cardiol, 1995,76: 8D- 13D
  • 6[7]Faiez Z, Brigitte D, Francois A. Treatment of congestive heart failure interfering the aldosterone- cardiac extracellular matrix relationship [ J ]. Hypertension,2001,38:1227 - 1232
  • 7Santos D J, Moreno AJ. Inhibition of heart mitochondrial lipid peroxidation by non - toxic concentrations of carvedilol and its analog BM - 910228. Biochem Pharmacol, 2001,61 (2) : 155- 164.
  • 8Feuerstein GZ, Bril A, Ruffolo RR et al . Protective effect of Carvedilil in the myocardium. Am J Cardio, 1997,80(11):41 -46.
  • 9Xie J, Dunn A, Tsikouris JP et al . A piacebo controlled evaluation of the antifibrillatory effect of Carvedilol. J Electrocardiol, 2001,34(1) :25 - 30.
  • 10Ruffolo RR Jr, Feuerstein GZ, Ohlstein EH et al . Recent observations with β- adrenoceptor blockade. AM J Hyper,1998,11(1):9- 15.

共引文献12

同被引文献52

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部